0000922423-12-000056.txt : 20120210 0000922423-12-000056.hdr.sgml : 20120210 20120210161211 ACCESSION NUMBER: 0000922423-12-000056 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20120210 DATE AS OF CHANGE: 20120210 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: COMPLETE GENOMICS INC CENTRAL INDEX KEY: 0001361103 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 203226545 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-85871 FILM NUMBER: 12593034 BUSINESS ADDRESS: STREET 1: 2071 STIERLIN COURT CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: (650) 943-2843 MAIL ADDRESS: STREET 1: 2071 STIERLIN COURT CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GILDER GAGNON HOWE & CO LLC CENTRAL INDEX KEY: 0000902464 IRS NUMBER: 133174112 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 2127652500 MAIL ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 26TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: GILDER GAGNON HOWE & CO DATE OF NAME CHANGE: 19930428 SC 13G/A 1 kl02006.htm SCHEDULE 13G FINAL AMENDMENT kl02006.htm  



SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
 
                   
 
SCHEDULE 13G

(Rule 13d-102)

Information to be Included in Statements Filed Pursuant to § 240.13d-1(b), (c) and (d) and Amendments
Thereto Filed Pursuant to § 240.13d-2.
 
Under the Securities Exchange Act of 1934

(Final Amendment)


Complete Genomics, Inc.
(Name of Issuer)

 
          Common Stock         
(Title of Class of Securities)
 
20454K104
(CUSIP Number)
 
                        January 31, 2012                     
(Date of Event Which Requires Filing of this Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
ý  Rule 13d-1(b)
¨  Rule 13d-1(c)
¨  Rule 13d-1(d)
 
                  
 
Page 1 of 6 Pages

 
 

 

13G
 
CUSIP No.  20454K104                                                                            Page 2 of 6 Pages
 
1)
NAME OF REPORTING PERSONS
 
Gilder, Gagnon, Howe & Co. LLC
 
2)
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)       o
(b)       o
3)
SEC USE ONLY
 
 
4)
CITIZENSHIP OR PLACE OF ORGANIZATION
 
New York
 
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5)
SOLE VOTING POWER
 
14,630
6)
SHARED VOTING POWER
 
None
7)
SOLE DISPOSITIVE POWER
 
14,630
8)
SHARED DISPOSITIVE POWER
 
1,320,950
9)
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,335,580
10)
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
o
11)
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
 
4.0%
12)
TYPE OF REPORTING PERSON
 
BD


 
 

 

Schedule 13G
 
Item 1(a).
Name of Issuer:
 
Complete Genomics, Inc.
 
Item 1(b).               Address of Issuer’s Principal Executive Offices:                                                                                                                     
 
2071 Stierlin Court
Mountain View, CA 94043
 
Item 2(a).               Name of Person Filing:

Gilder, Gagnon, Howe & Co. LLC
 
Item 2(b).
Address of Principal Business Office or, if None, Residence:
 
3 Columbus Circle, 26th Floor
New York, NY 10019
 
Item 2(c).
Citizenship:
 
New York
 
Item 2(d).
Title of Class of Securities:
 
Common Stock
 
Item 2(e).
CUSIP Number:
 
20454K104
 
Item 3.                    If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
 
 
(a)
x
Broker or Dealer registered under Section 15 of the Act (15 U.S.C. 78o);
 
 
(b)
¨
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
 
 
(c)
¨
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
 
 
(d)
¨
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
 
 
(e)
¨
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
 
 
(f)
¨
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
 
 
(g)
¨
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
 
 
 
 
 

 
 
 
 
(h)
¨
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
 
 
(i)
¨
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);
 
 
(j)
¨
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);
 
 
(k)
¨
Group, in accordance with § 240.13d-1(b)(1)(ii)(K).
 
Item 4.
Ownership.
 
 
(a)
Amount beneficially owned:  1,335,580
 
 
(b)
Percent of class:  4.0%
 
 
(c)
Number of shares as to which such person has:
 
 
(i)
Sole power to vote or to direct the vote:  14,630
 
 
(ii)
Shared power to vote or to direct the vote:  None
 
 
(iii)
Sole power to dispose or to direct the disposition of:  14,630
 
 
(iv)
Shared power to dispose or to direct the disposition of:  1,320,950
 
 
The shares reported include 990,426 shares held in customer accounts over which partners and/or employees of the Reporting Person have discretionary authority to dispose of or direct the disposition of the shares, 330,524 shares held in accounts owned by the partners of the Reporting Person and their families, and 14,630 shares held in the account of the profit-sharing plan of the Reporting Person (the “Profit-Sharing Plan”).
 
Item 5.
Ownership of Five Percent or Less of a Class.
 
This statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities.
 
Item 6.
Ownership of More than Five Percent on Behalf of Another Person.
 
Not applicable
 
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
 
Not applicable
 

 
 
 

 
 
 
 
Item 8.
Identification and Classification of Members of the Group.
 
Not applicable
 
Item 9.
Notice of Dissolution of Group.
 
Not applicable
 
Item 10.
Certification.
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
 
 

 
 
 

 

SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
 
February 8, 2012                                                                               
    Date
 
 
/s/ Bonnie Haupt                                                                             
    Signature
 
 
Bonnie Haupt, Chief Compliance Officer & Branch Manager
    Name/Title